+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Blepharitis Drugs Market 2019-2023 - Product Image

Global Blepharitis Drugs Market 2019-2023

  • ID: 4808295
  • Report
  • July 2019
  • Region: Global
  • 124 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Akorn Inc.
  • Allergan Plc
  • Novartis AG
  • Pfizer Inc.
  • MORE
Global Blepharitis Drugs Market: About this market

Blepharitis drugs include steroids and antibiotics, which are used to treat inflammation in the eyelids and infection. The blepharitis drugs market analysis considers sales from the steroids and antibiotics segments. Our analysis also considers the sales of blepharitis drugs in Asia, Europe, North America, and ROW. In 2018, the steroids segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the expected approval of late-stage molecules and the high efficacy of steroids in treating inflammations in the eyelids will significantly help the market segment in maintaining its leading position. Also, our global blepharitis drugs report has observed market growth factors such as high-risk factors of blepharitis, growing awareness about eye conditions, and increasing use of combination drugs. However, lack of approved therapies to treat blepharitis, antimicrobial resistance, and development of novel treatment procedures may hamper the growth of the blepharitis drugs industry over the forecast period.

Global Blepharitis Drugs Market: Overview

Increasing use of combination drugs

The use of combination of off-label steroids and antibiotics is increasing to treat blepharitis owing to the lack of availability of approved therapies and their proven advantages over monotherapy. As a result, vendors are recording increased sales, which will contribute to the growth of the market over the forecast period. The blepharitis drugs market will record a CAGR over 5% during 2019-2023.

Development of novel drug formulations

Although antibiotics and steroids are commonly used for the symptomatic treatment of blepharitis, there is a high unmet need for novel therapies with high efficacy and fewer side-effects. As a result, vendors have a significant growth potential in the market and have started developing novel therapeutics. Therefore, this trend will have a positive impact on the overall market growth.

Competitive Landscape

With the presence of several major players, the global blepharitis drugs market is fragmented. The robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading blepharitis drugs manufacturers, which include Akorn Inc., Allergan Plc, Bausch Health Companies Inc., Novartis AG, and Pfizer Inc.

Also, the blepharitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Akorn Inc.
  • Allergan Plc
  • Novartis AG
  • Pfizer Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Steroids - Market size and forecast 2018-2023
  • Antibiotics - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akorn Inc.
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Novartis AG
  • Pfizer Inc.
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Steroids - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Steroids - Year-over-year growth 2019-2023 (%)
Exhibit 22: Antibiotics - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Antibiotics - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Some of the combination drugs available in the market
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Recent strategic alliances in ophthalmology:
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Akorn Inc. - Vendor overview
Exhibit 51: Akorn Inc. - Business segments
Exhibit 52: Akorn Inc. - Organizational developments
Exhibit 53: Akorn Inc. - Segment focus
Exhibit 54: Akorn Inc. - Key offerings
Exhibit 55: Akorn Inc. - Key customers
Exhibit 56: Allergan Plc - Vendor overview
Exhibit 57: Allergan Plc - Product segments
Exhibit 58: Allergan Plc - Organizational developments
Exhibit 59: Allergan Plc - Geographic focus
Exhibit 60: Allergan Plc - Segment focus
Exhibit 61: Allergan Plc - Key offerings
Exhibit 62: Allergan Plc - Key customers
Exhibit 63: Bausch Health Companies Inc. - Vendor overview
Exhibit 64: Bausch Health Companies Inc. - Business segments
Exhibit 65: Bausch Health Companies Inc. - Organizational developments
Exhibit 66: Bausch Health Companies Inc. - Geographic focus
Exhibit 67: Bausch Health Companies Inc. - Segment focus
Exhibit 68: Bausch Health Companies Inc. - Key offerings
Exhibit 69: Bausch Health Companies Inc. - Key customers
Exhibit 70: Novartis AG - Vendor overview
Exhibit 71: Novartis AG - Business segments
Exhibit 72: Novartis AG - Organizational developments
Exhibit 73: Novartis AG - Geographic focus
Exhibit 74: Novartis AG - Segment focus
Exhibit 75: Novartis AG - Key offerings
Exhibit 76: Novartis AG - Key customers
Exhibit 77: Pfizer Inc. - Vendor overview
Exhibit 78: Pfizer Inc. - Business segments
Exhibit 79: Pfizer Inc. - Organizational developments
Exhibit 80: Pfizer Inc. - Geographic focus
Exhibit 81: Pfizer Inc. - Segment focus
Exhibit 82: Pfizer Inc. - Key offerings
Exhibit 83: Pfizer Inc. - Key customers
Exhibit 84: Validation techniques employed for market sizing
Exhibit 85: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Akorn Inc.
  • Allergan Plc
  • Novartis AG
  • Pfizer Inc.
  • MORE
The following companies are recognised as the key players in the global blepharitis drugs market: Akorn Inc., Allergan Plc, Bausch Health Companies Inc., Novartis AG, and Pfizer Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the development of novel drug formulations.”

According to the report, one of the major drivers for this market is the increasing use of combination drugs.

Further, the report states that one of the major factors hindering the growth of this market is the lack of approved therapies to treat blepharitis.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Akorn Inc.
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Novartis AG
  • Pfizer Inc.
Note: Product cover images may vary from those shown
Adroll
adroll